Tom Bosch - Director Quality Processes, Clinical Registry Team Lead - Janssen, Pharmaceutical Companies of Johnson and Johnson | LinkedIn
![Thomas Quante to become CEO of Bosch Building Technologies | Bosch Security and Safety Systems I Global Thomas Quante to become CEO of Bosch Building Technologies | Bosch Security and Safety Systems I Global](https://media.boschsecurity.com/fs/media/pb/images/news/press_releases/press_releases_2021/thomas_quante_becomes_ceo_of_bosch_bt/Thomas_Quante_CEO_BT.jpg)
Thomas Quante to become CEO of Bosch Building Technologies | Bosch Security and Safety Systems I Global
![Tom BOSCH | Director, Head of Clinical Registry | PhD | Janssen Biologics, Leiden | BioResearch Quality & Compliance | Research profile Tom BOSCH | Director, Head of Clinical Registry | PhD | Janssen Biologics, Leiden | BioResearch Quality & Compliance | Research profile](https://i1.rgstatic.net/ii/profile.image/774714532319234-1561717746845_Q512/Tom-Bosch.jpg)
Tom BOSCH | Director, Head of Clinical Registry | PhD | Janssen Biologics, Leiden | BioResearch Quality & Compliance | Research profile
![Thomas Bosch directeur/lid managementteam van de Fiscale Inlichtingen- en Opsporingsdienst | Nieuwsbericht | Algemene Bestuursdienst Thomas Bosch directeur/lid managementteam van de Fiscale Inlichtingen- en Opsporingsdienst | Nieuwsbericht | Algemene Bestuursdienst](https://www.algemenebestuursdienst.nl/binaries/large/content/gallery/abd/content-afbeeldingen/personen-abd-managers/2021/thomas-bosch.jpg)